The SITC Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG Mobile App features evidence- and expert consensus-based recommendations on important aspects of immunotherapy treatment as well as interactive tools and companion educational resources. Covering a range of topics, from biomarkers and therapy selection to quality of life and management of immune-related adverse events, busy clinicians will find the SITC CPG Mobile App as the go-to resource on when and how to use immunotherapy to help improve outcomes for patients with cancer.
The SITC Cancer Immunotherapy Guidelines are a collection of clinical practice guidelines (CPGs) developed by leading experts to help hematologists and oncologists determine when and how to best use immunotherapy to treat their patients. The published guidelines provide evidence- and expert consensus-based recommendations on topics including selection of appropriate immunotherapy treatments, toxicity management, biomarkers, and considerations for patient quality of life. SITC has published CPGs covering a variety of hematologic malignancies, solid tumors, and toxicity management.
SITC would like to thank the 2023 sponsors for their generous support of the mobile app.
No sponsors were directly nor indirectly involved with the development of the content in the SITC Guidelines or any other scientific content within this mobile app.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org